Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001108205-23-000077
Filing Date
2023-12-21
Accepted
2023-12-21 16:00:47
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cris-20221231.htm   iXBRL 10-K/A 215136
2 EX-31.3 cris-12312022x10kaexx313.htm EX-31.3 10517
3 EX-31.4 cris-12312022x10kaexx314.htm EX-31.4 10502
  Complete submission text file 0001108205-23-000077.txt   452627

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20221231.xsd EX-101.SCH 2512
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20221231_lab.xml EX-101.LAB 38362
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20221231_pre.xml EX-101.PRE 20359
9 EXTRACTED XBRL INSTANCE DOCUMENT cris-20221231_htm.xml XML 5268
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30347 | Film No.: 231505210
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)